This trial will compare the safety of two inhalers for COPD over 12-52 weeks.
- Chronic Obstructive Pulmonary Disease (COPD)
8 Primary · 0 Secondary · Reporting Duration: Week 4, 8 and 52 (if attending 56 weeks study)
Awards & Highlights
2 Treatment Groups
BGF MDI HFA 320/14.4/9.6 μg
1 of 2
BGF MDI HFO 320/14.4/9.6μg
1 of 2
542 Total Participants · 2 Treatment Groups
Primary Treatment: BGF MDI HFO 320/14.4/9.6μg · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 40 - 80 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||33.3%|
How many prior treatments have patients received?
Why did patients apply to this trial?
- "I have tried several inhalers but my lung capacity is slowly going down. It is presently at 47% capacity!"
Frequently Asked Questions
Can seniors participate in this research?
"Enrolment for this particular trial is restricted to patients aged 40 to 80. However, there are other 36 trials for patients under 18 and 479 trials for those over 65." - Anonymous Online Contributor
To whom is this treatment opportunity available?
"To take part in this experiment, individuals must have chronic obstructive airway disease and be between 40 and 80 years old. Currently, the trial is looking for 542 individuals in total." - Anonymous Online Contributor
Is this trial overseen by a large team or a small one?
"The 31 sites for this trial are located in various cities, including Clearwater, Ajax and Sarasota. It may be helpful to select the clinic nearest to you, to reduce the amount of travel required." - Anonymous Online Contributor
Has the FDA cleared BGF MDI HFO 320/14.4/9.6μg for general use?
"BGF MDI HFO 320/14.4/9.6μg is in Phase 3 of clinical trials, which suggests that there is some evidence of efficacy and that the safety of the drug has been supported by multiple rounds of testing." - Anonymous Online Contributor